Skip to main content

Main menu

  • Home
  • Articles
    • Current Issue
    • Next in The JI
    • Archive
    • Brief Reviews
    • Pillars of Immunology
    • Translating Immunology
    • Most Read
    • Top Downloads
    • Annual Meeting Abstracts
  • COVID-19/SARS/MERS Articles
  • Info
    • About the Journal
    • For Authors
    • Journal Policies
    • Influence Statement
    • For Advertisers
  • Editors
  • Submit
    • Submit a Manuscript
    • Instructions for Authors
    • Journal Policies
  • Subscribe
    • Journal Subscriptions
    • Email Alerts
    • RSS Feeds
    • ImmunoCasts
  • More
    • Most Read
    • Most Cited
    • ImmunoCasts
    • AAI Disclaimer
    • Feedback
    • Help
    • Accessibility Statement
  • Other Publications
    • American Association of Immunologists
    • ImmunoHorizons

User menu

  • Subscribe
  • Log in

Search

  • Advanced search
The Journal of Immunology
  • Other Publications
    • American Association of Immunologists
    • ImmunoHorizons
  • Subscribe
  • Log in
The Journal of Immunology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Next in The JI
    • Archive
    • Brief Reviews
    • Pillars of Immunology
    • Translating Immunology
    • Most Read
    • Top Downloads
    • Annual Meeting Abstracts
  • COVID-19/SARS/MERS Articles
  • Info
    • About the Journal
    • For Authors
    • Journal Policies
    • Influence Statement
    • For Advertisers
  • Editors
  • Submit
    • Submit a Manuscript
    • Instructions for Authors
    • Journal Policies
  • Subscribe
    • Journal Subscriptions
    • Email Alerts
    • RSS Feeds
    • ImmunoCasts
  • More
    • Most Read
    • Most Cited
    • ImmunoCasts
    • AAI Disclaimer
    • Feedback
    • Help
    • Accessibility Statement
  • Follow The Journal of Immunology on Twitter
  • Follow The Journal of Immunology on RSS

Sodium-dependent glucose transporter-1 as a novel immunological player in the intestinal mucosa.

M. Palazzo, S. Gariboldi, L. Zanobbio, S. Selleri, G. F. Dusio, V. Mauro, A. Rossini, A. Balsari and Cr. Rumio
J Immunol November 15, 2008, 181 (10) 7428; DOI: https://doi.org/10.4049/jimmunol.181.10.7428
M. Palazzo
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
S. Gariboldi
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
L. Zanobbio
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
S. Selleri
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
G. F. Dusio
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
V. Mauro
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
A. Rossini
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
A. Balsari
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Cr. Rumio
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Palazzo, M., S. Gariboldi, L. Zanobbio, S. Selleri, G. F. Dusio, V. Mauro, A. Rossini, A. Balsari, and Cr. Rumio. 2008. Sodium-dependent glucose transporter-1 as a novel immunological player in the intestinal mucosa. J. Immunol. 181: 3126–3137 .

In Results, under the subhead titled SGLT-1 activation blocks NF-κB nuclear translocation induced by LPS and CpG-ODN, the corrected text in the fourth, fifth, and six sentences of the paragraph should read as follows: “In HT-29, LCC-18, and STC-1 cells stimulated with LPS or CpG-ODN, we observed activation of NF-κB, i.e., translocation to the nucleus, whereas this activation was not detected in cells pretreated with d-glucose (Fig. 6⇓A) or 3-OMG (data not shown). NF-κB in the cytoplasm is complexed to members of the IκB family of inhibitory proteins. Western blot analysis revealed degradation of IκB when NF-κB translocates to the nucleus upon LPS or CpG-ODN stimulation; degradation of IκB in stimulated cells was inhibited by d-glucose (Fig. 6⇓B) or 3-OMG (data not shown) pretreatment.”

In addition, changes have been made in Fig. 6⇓ concerning the Western blots in B for LCC-18 and STC-1 and minor changes have also been made to the figure legend. Both the revised Fig. 6⇓ and the revised legend are shown below.

           FIGURE 6.
  • Download figure
  • Open in new tab
  • Download powerpoint
FIGURE 6.

A, Western blot analysis for NF-κB in IEC nuclear extracts. HT29, LCC-18, and STC-1 cells were stimulated with LPS or CpG-ODN with or without d-glucose pretreatment. Nuclear extracts were analyzed by Western blotting with anti-NF-κB p65 Ab. B, Western blot analysis for IκB in IEC extracts. HT29, LCC-18, and STC-1 cells were stimulated with LPS or CpG-ODN with or without d-glucose pretreatment. Total protein extracts were analyzed by Western blotting with anti-IκB Ab. C, Involvement of Akt signaling pathway. HT29 protein extracts, following LPS and/or glucose treatment, were analyzed by Western blotting with anti-phospho-Akt and anti-Akt Abs (C1). In addition, cells were stimulated with LPS, with or without d-glucose pretreatment, in the presence or absence of Akt inhibitor LY294002. Nuclear extracts were analyzed by Western blotting with anti-NF-κB p65 Ab (C2). Untr, Untreated.

  • Copyright © 2008 by The American Association of Immunologists
PreviousNext
Back to top

In this issue

The Journal of Immunology: 181 (10)
The Journal of Immunology
Vol. 181, Issue 10
15 Nov 2008
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Advertising (PDF)
  • Back Matter (PDF)
  • Editorial Board (PDF)
  • Front Matter (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word about The Journal of Immunology.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Sodium-dependent glucose transporter-1 as a novel immunological player in the intestinal mucosa.
(Your Name) has forwarded a page to you from The Journal of Immunology
(Your Name) thought you would like to see this page from the The Journal of Immunology web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Sodium-dependent glucose transporter-1 as a novel immunological player in the intestinal mucosa.
M. Palazzo, S. Gariboldi, L. Zanobbio, S. Selleri, G. F. Dusio, V. Mauro, A. Rossini, A. Balsari, Cr. Rumio
The Journal of Immunology November 15, 2008, 181 (10) 7428; DOI: 10.4049/jimmunol.181.10.7428

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Sodium-dependent glucose transporter-1 as a novel immunological player in the intestinal mucosa.
M. Palazzo, S. Gariboldi, L. Zanobbio, S. Selleri, G. F. Dusio, V. Mauro, A. Rossini, A. Balsari, Cr. Rumio
The Journal of Immunology November 15, 2008, 181 (10) 7428; DOI: 10.4049/jimmunol.181.10.7428
del.icio.us logo Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like

Jump to section

  • Article
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • Correction: Myeloid-Specific Deficiency of Long-Chain Acyl CoA Synthetase 4 Reduces Inflammation by Remodeling Phospholipids and Reducing Production of Arachidonic Acid–Derived Proinflammatory Lipid Mediators
  • Correction: African Swine Fever Virus pI215L Negatively Regulates cGAS-STING Signaling Pathway through Recruiting RNF138 to Inhibit K63-Linked Ubiquitination of TBK1
  • Correction: Loss of Invariant Chain Protects Nonobese Diabetic Mice against Type 1 Diabetes
Show more CORRECTIONS

Similar Articles

Navigate

  • Home
  • Current Issue
  • Next in The JI
  • Archive
  • Brief Reviews
  • Pillars of Immunology
  • Translating Immunology

For Authors

  • Submit a Manuscript
  • Instructions for Authors
  • About the Journal
  • Journal Policies
  • Editors

General Information

  • Advertisers
  • Subscribers
  • Rights and Permissions
  • Accessibility Statement
  • FAR 889
  • Privacy Policy
  • Disclaimer

Journal Services

  • Email Alerts
  • RSS Feeds
  • ImmunoCasts
  • Twitter

Copyright © 2022 by The American Association of Immunologists, Inc.

Print ISSN 0022-1767        Online ISSN 1550-6606